Perrigo Co. PLC won't have strong quarterly results to help management convince investors about their turnaround strategy that swings on a change the firm says started during its latest quarter, moving from health care to self-care.
However, during its first-quarter results and investor day conference on May 9, the Dublin-based firm, which has remained the dominant OTC drug private label and store brand provider during its lengthy slump in net income and earnings, will report another step in its move to return to being consumer product-focused
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?